216 results on '"Sengupta, Jay"'
Search Results
2. Abstract 16980: Real World Performance of a Conduction System Pacing Lead
3. Abstract 16848: Reduced Survival of Patients Treated With Leadless Right Ventricular Pacemakers
4. Post-Shock Asystole in Patients Dying Out of Hospital While Wearing a Cardioverter Defibrillator
5. Causes and clinical consequences of inappropriate shocks experienced by patients wearing a cardioverter-defibrillator
6. Magnetic field interactions between current consumer electronics and cardiac implantable electronic devices
7. Ripple Frequency Determined via a Novel Algorithm Is Associated With Atrial Fibrillation Termination and Freedom From Atrial Fibrillation
8. Reliability and longevity of implantable defibrillators
9. Interventional electrophysiology at a crossroads
10. Abstract 15091: Cardiac Ct-Guided Exclusion of Left Atrial Appendage Thrombus Prior to Electrical Cardioversion for Atrial Fibrillation
11. Abstract 235: Post-shock Asystole And Inappropriate Shocks In Patients Dying Out-of-hospital While Wearing A Defibrillator
12. Miocardite Aguda como Apresentação Inicial da Mutação da Desmoplaquina – Ampliando o Diagnóstico Diferencial
13. Acute Myocarditis as the Initial Presentation of Desmoplakin Mutation – Broadening the Differential Diagnosis
14. Failure to Defibrillate or Cardiovert Due to Premature Truncation of Biphasic Shocks from Implantable Defibrillators
15. Major adverse clinical events associated with implantation of a leadless intracardiac pacemaker
16. Short- and Long-Term Outcomes in Patients With New-Onset Persistent Left Bundle Branch Block After Transcatheter Aortic Valve Replacement
17. High shocking and pacing impedances due to defibrillation lead calcification
18. Internal insulation breaches in an implantable cardioverter-defibrillator lead with redundant conductors
19. Impact of Atrial Fibrillation on the Outcomes after MitraClip®: A Meta-Analysis
20. PO-05-013 GLOBAL TRENDS IN LEADLESS PACEMAKER PERFORATIONS AND MORTALITY
21. PO-04-168 CAUSES AND CONSEQUENCES OF INAPPROPRIATE SHOCKS DELIVERED BY A WEARABLE DEFIBRILLATOR
22. PO-05-025 LONGER TERM OUTCOMES IN PATIENTS PRECLUDED FOR TRANSVENOUS PACEMAKER IMPLANTATION: EXPERIENCE WITH THE MICRA VR TRANSCATHETER PACEMAKER
23. SURVIVAL OF PATIENTS PACED WITH LEADLESS VERSUS CONDUCTION SYSTEM PACEMAKERS
24. TWO HEARTS OF A KIND
25. DESMOPLAKIN GENE MUTATION IS ASSOCIATED WITH MYOCARDITIS-LIKE PRESENTATION OF ARRHYTHMOGENIC CARDIOMYOPATHY
26. The Impact and Outcomes of Right Ventricular Lead Extraction in CIED-Related Tricuspid Regurgitation
27. PO-03-036 MAJOR ADVERSE CLINICAL EVENTS AND DEVICE PROBLEMS DURING AND EARLY AFTER LEADLESS PACEMAKER IMPLANTATION: A COMPARISON OF TWO DEVICE DESIGNS.
28. PO-02-023 'SEARCH AV' BEHAVIOR OBSERVED IN DOO PACING MODE.
29. MP-470552-002 NOVEL ASSOCIATION OF ARRHYTHMOGENIC CARDIOMYOPATHY (ACM) WITH A RARELY DESCRIBED VARIANT OF THE FLNC GENE. A REPORT OF A LARGE MULTIGENERATIONAL FAMILY.
30. PO-621-05 MAGNETIC FIELD INTERACTIONS BETWEEN CONTEMPORARY ELECTRONIC CONSUMER PRODUCTS AND CARDIAC IMPLANTABLE ELECTRONIC DEVICES
31. PO-652-03 HARNESSING BIG DATA TO TRACK QUALITY FOR INTERVENTIONAL ELECTROPHYSIOLOGY PROCEDURES
32. PO-632-01 TRICUSPID VALVE ADVERSE EVENTS DURING LEADLESS PACEMAKER IMPLANTATION
33. In-Hospital and Readmission Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement
34. Leadless pacemaker perforations: Clinical consequences and related device and user problems
35. Ripple Frequency Determined via a Novel Algorithm is Associated with Atrial Fibrillation Termination and Freedom from Atrial Fibrillation
36. Acute Myocardial Infarction-Like Events in Related Patients With a Desmoplakin-Associated Arrhythmogenic Cardiomyopathy
37. TCT-195 In-Hospital and Readmission Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement
38. B-PO03-088 ATRIAL FIBRILLATION TERMINATION AND FREEDOM FROM ATRIAL FIBRILLATION IS ASSOCIATED WITH ABLATION OF ATRIAL REGIONS WITH HIGHER RIPPLE FREQUENCY
39. B-PO02-037 INCREASING NUMBER OF SERIOUS ADVERSE EVENTS DURING AND AFTER LEADLESS PACEMAKER IMPLANTATION
40. TIME TO FIRST SHOCK OR NO SHOCK: LONG-TERM FOLLOW-UP OF HYPERTROPHIC CARDIOMYOPATHY PATIENTS TREATED WITH AN IMPLANTABLE DEFIBRILLATOR
41. MATCHING IMPLANTABLE DEFIBRILLATOR LONGEVITY WITH PATIENT SURVIVAL: CLINICAL AND ECONOMIC SIGNIFICANCE OF NEW BATTERY TECHNOLOGIES
42. An emblematic defibrillator problem
43. An Emblematic Defibrillator Problem
44. Optimal management of acute aortic dissection
45. Contributors
46. Cardiogenic Shock after Myocardial Infarction
47. Chronic Coronary Artery Disease
48. 24 - Cardiogenic Shock After Myocardial Infarction
49. MITRAL VALVE PROLAPSE: WHEN DOES IT STOP BEING BENIGN?
50. LATE GADOLINIUM ENHANCEMENT IS ASSOCIATED WITH ADVANCED BIVENTRICULAR DYSFUNCTION IN PATIENTS WITH ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.